Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 117544
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.117544
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.117544
Table 9 Multivariable logistic regression for predictors of Helicobacter pylori eradication failure and for the composite endpoint of peptic ulcer bleeding or cardiovascular disease progression at 6 months
| Variable | Adjusted odds ratio | 95%CI | P value |
| Predictors of PUB | |||
| H. pylori infection | 4.2 | 2.1-8.3 | < 0.001 |
| Low albumin levels | 2.8 | 1.5-5.2 | 0.002 |
| Diabetes mellitus | 1.2 | 0.8-1.9 | 0.35 |
| Poor adherence | 3.1 | 1.8-5.4 | < 0.001 |
| Predictors of CV disease progression | |||
| H. pylori infection | 3.2 | 1.7-6.0 | < 0.001 |
| Multivessel coronary disease at baseline | 2.8 | 1.5-5.2 | 0.001 |
| Diabetes mellitus | 1.5 | 1.0-2.4 | 0.04 |
| Poor adherence | 2.1 | 1.1-3.9 | 0.012 |
- Citation: Semeya AA, Makled WA, Elnagdy MA, Elgamal R, Othman AAA. Helicobacter pylori eradication and the prevention of peptic ulcer bleeding and cardiovascular disease progression in chronic aspirin users. World J Gastroenterol 2026; 32(17): 117544
- URL: https://www.wjgnet.com/1007-9327/full/v32/i17/117544.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i17.117544